Reports for TEVA-BUPRENORPHINE/NALOXONE
Brand name
TEVA-BUPRENORPHINE/NALOXONE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02453908 |
Ingredients
BUPRENORPHINE NALOXONE |
Ingredient Strength
2 MG 0.5 MG |
ATC Code
N07BCN07BC |
ATC Descriptor
DRUGS USED IN ADDICTIVE DISORDERS DRUGS USED IN ADDICTIVE DISORDERS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-BUPRENORPHINE/NALOXONE | 30 | Resolved | 2019-10-03 | 2020-01-24 | 95396 |
TEVA-BUPRENORPHINE/NALOXONE | 30 | Resolved | 2021-05-20 | 2021-06-03 | 139725 |
TEVA-BUPRENORPHINE/NALOXONE | 30 | Resolved | 2021-08-27 | 2021-09-16 | 144704 |
TEVA-BUPRENORPHINE/NALOXONE | 30 | Resolved | 2022-08-18 | 2022-12-02 | 167203 |
TEVA-BUPRENORPHINE/NALOXONE | 30 | Actual shortage | 2024-03-07 | 2024-06-07 | 221534 |
TEVA-BUPRENORPHINE/NALOXONE | 30 bot | Resolved | 2021-06-03 | 2021-06-10 | 140363 |
Showing 1 to 6 of 6
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0